Development of novel drugs from marine surface associated microorganisms

Marine Drugs

Volumn 8, Issue 3, 2010, Pages 438-459

  Penesyan, Anahit ^a   Kjelleberg, Staffan ^a   Egan, Suhelen ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Antimicrobial, natural products; Bioactive; Marine epibiotic microoorganisms

Indexed keywords

ANTIBIOTIC AGENT; AZASPIRACID; BREVETOXIN; EPOTHILONE DERIVATIVE; HISTRIONICOTOXIN; NATURAL PRODUCT; BIOLOGICAL PRODUCT; SEA WATER;

ANTIMICROBIAL ACTIVITY; BACTERIUM CULTURE; BACTERIUM ISOLATION; DRUG IDENTIFICATION; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; EUKARYOTE; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; MARINE ENVIRONMENT; MASS SPECTROMETRY; METAGENOMICS; MICROBIAL COMMUNITY; NONHUMAN; PURIFICATION; REVIEW; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; DRUG DEVELOPMENT; ECOSYSTEM; ISOLATION AND PURIFICATION; MARINE BIOLOGY; MICROBIOLOGY; PROCEDURES; TRENDS;

EUKARYOTA;

BIOLOGICAL PRODUCTS; DRUG DISCOVERY; ECOSYSTEM; MARINE BIOLOGY; SEAWATER; WATER MICROBIOLOGY;

EID: 77952495893     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md8030438     Document Type: Review

References (188)

1. Berdy, J. Bioactive microbial metabolites. A personal view. J. Antibiot. (Tokyo) 2005, 58, 1-26.
2. Monaghan, R.L.; Tkacz, J.S. Bioactive microbial products: Focus upon mechanism of action. Annu. Rev. Microbiol. 1990, 44, 271-301.
3. Capon, R.J. Marine bioprospecting-Trawling for treasure and pleasure. European J. Org. Chem. 2001, 633-645.
4. Basilio, A.; Gonzalez, I.; Vicente, M.F.; Gorrochategui, J.; Cabello, A.; Gonzalez, A.; Genilloud, O. Patterns of antimicrobial activities from soil actinomycetes isolated under different conditions of pH and salinity. J. Appl. Microbiol. 2003, 95, 814-823. (Pubitemid 37186665)
5. Pelaez, F.; Genilloud, O. Discovering new drugs from microbial natural products. In Microorganisms for Health Care, Food and Enzyme Production; Barredo, J.L., Ed.; Research Signpost: Trivendrum, India, 2003; 1-23.
6. Watve, M.G.; Tickoo, R.; Jog, M.M.; Bhole, B.D. How many antibiotics are produced by the genus Streptomyces? Arch. Microbiol. 2001, 176, 386-390.
7. Rheinheimer, G. Aquatic microbiology; Wiley: Chichester; New York, NY, USA, 1992.
8. Fenical, W.; Jensen, P.R. Developing a new resource for drug discovery: Marine actinomycete bacteria. Nat. Chem. Biol. 2006, 2, 666-673.
9. Perez-Matos, A.E.; Rosado, W.; Govind, N.S. Bacterial diversity associated with the Caribbean tunicate Ecteinascidia turbinata. Antonie van Leeuwenhoek 2007, 92, 155-164.
10. Longford, S.R.; Tujula, N.A.; Crocetti, G.R.; Holmes, A.J.; Holmstrom, C.; Kjelleberg, S.; Steinberg, P.D.; Taylor, M.W. Comparisons of diversity of bacterial communities associated with three sessile marine eukaryotes. Aquat. Microb. Ecol. 2007, 48, 217-229.
11. Santiago-Vazquez, L.Z.; Bruck, T.B.; Bruck, W.M.; Duque-Alarcon, A.P.; McCarthy, P.J.; Kerr, R.G. The diversity of the bacterial communities associated with the azooxanthellate hexacoral Cirrhipathes lutkeni. ISME J. 2007, 1, 654-659. (Pubitemid 350076522)
12. Rohwer, F.; Seguritan, V.; Azam, F.; Knowlton, N. Diversity and distribution of coral-associated bacteria. Mar. Ecol. Prog. Ser. 2002, 243, 1-10.
13. Martinez-Garcia, M.; Diaz-Valdes, M.; Wanner, G.; Ramos-Espla, A.; Anton, J. Microbial community associated with the colonial ascidian Cystodytes dellechiajei. Environ. Microbiol. 2007, 9, 521-534. (Pubitemid 46072138)
14. Webster, N.S.; Bourne, D. Bacterial community structure associated with the Antarctic soft coral, Alcyonium antarcticum. FEMS Microbiol. Ecol. 2007, 59, 81-94.
15. Bourne, D.G.; Munn, C.B. Diversity of bacteria associated with the coral Pocillopora damicornis from the Great Barrier Reef. Environ. Microbiol. 2005, 7, 1162-1174.
16. Enticknap, J.J.; Kelly, M.; Peraud, O.; Hill, R.T. Characterization of a culturable alphaproteobacterial symbiont common to many marine sponges and evidence for vertical transmission via sponge larvae. Appl. Environ. Microbiol. 2006, 72, 3724-3732.
17. Penesyan, A.; Marshall-Jones, Z.; Holmstrom, C.; Kjelleberg, S.; Egan, S. Antimicrobial activity observed among cultured marine epiphytic bacteria reflects their potential as a source of new drugs: Research article. FEMS Microbiol. Ecol. 2009, 69, 113-124.
18. Hentschel, U.; Schmid, M.; Wagner, M.; Fieseler, L.; Gernert, C.; Hacker, J. Isolation and phylogenetic analysis of bacteria with antimicrobial activities from the Mediterranean sponges Aplysina aerophoba and Aplysina cavernicola. FEMS Microbiol. Ecol. 2001, 35, 305-312.
19. Muscholl-Silberhorn, A.; Thiel, V.; Imhoff, J. Abundance and bioactivity of cultured sponge-sssociated bacteria from the Mediterranean sea. Microb. Ecol. 2008, 55, 94-106.
20. Burgess, J.G.; Jordan, E.M.; Bregu, M.; Mearns-Spragg, A.; Boyd, K.G. Microbial antagonism: A neglected avenue of natural products research. J. Biotechnol. 1999, 70, 27-32.
21. Egan, S.; Thomas, T.; Kjelleberg, S. Unlocking the diversity and biotechnological potential of marine surface associated microbial communities. Curr. Opin. Microbiol. 2008, 11, 219-225.
22. Zobell, C.E. Marine microbiology: A Monograph on Hydrobacteriology; Chronica Botanica Co.: Waltham, MA, USA, 1946.
23. Sogin, M.L.; Morrison, H.G.; Huber, J.A.; Welch, D.M.; Huse, S.M.; Neal, P.R.; Arrieta, J.M.; Herndl, G.J. Microbial diversity in the deep sea and the underexplored "rare biosphere". Proc. Natl. Acad. Sci. USA 2006, 103, 12115-12120.
24. Stach, J.E.M.; Bull, A.T. Estimating and comparing the diversity of marine actinobacteria. Antonie van Leeuwenhoek 2005, 87, 3-9.
25. Holler, U.; Wright, A.D.; Matthee, G.F.; Konig, G.M.; Draeger, S.; Aust, H.J.; Schulz, B. Fungi from marine sponges: Diversity, biological activity and secondary metabolites. Mycol. Res. 2000, 104, 1354-1365.
26. Haefner, B. Drugs from the deep: Marine natural products as drug candidates. Drug Discov. Today 2003, 8, 536-544.
27. Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2009, 26, 170-244.
28. Andrighetti-Frohner, C.R.; Antonio, R.V.; Creczynski-Pasa, T.B.; Barardi, C.R.M.; Simoes, C.M.O. Cytotoxicity and potential antiviral evaluation of violacein produced by Chromobacterium violaceum. Mem. Inst. Oswaldo Cruz 2003, 98, 843-848.
29. Lichstein, H.C.; Van de Sand, V.F. Violacein, an antibiotic pigment produced by Chromobacterium violaceum. J. Infect. Dis. 1945, 76, 47-51.
30. Matz, C.; Deines, P.; Boenigk, J.; Arndt, H.; Eberl, L.; Kjelleberg, S.; Jurgens, K. Impact of violacein-producing bacteria on survival and feeding of bacterivorous nanoflagellates. Appl. Environ. Microbiol. 2004, 70, 1593-1599.
31. James, S.G.; Holmstrom, C.; Kjelleberg, S. Purification and characterization of a novel antibacterial protein from the marine bacterium D2. Appl. Environ. Microbiol. 1996, 62, 2783-2788.
32. Franks, A.; Haywood, P.; Holmstrom, C.; Egan, S.; Kjelleberg, S.; Kumar, N. Isolation and structure elucidation of a novel yellow pigment from the marine bacterium Pseudoalteromonas tunicata. Molecules 2005, 10, 1286-1291.
33. Feling, R.H.; Buchanan, G.O.; Mincer, T.J.; Kauffman, C.A.; Jensen, P.R.; Fenical, W. Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angewandte Chemie-International Edition 2003, 42, 355-357.
34. Ratnayake, R.; Lacey, E.; Tennant, S.; Gill, J.H.; Capon, R.J. Kibdelones: Novel anticancer polyketides from a rare Australian actinomycete. Chemistry-A European Journal 2007, 13, 1610-1619.
35. Fremlin, L.J.; Piggott, A.M.; Lacey, E.; Capon, R.J. Cottoquinazoline A and cotteslosins A and B, metabolites from an Australian marine-derived strain of Aspergillus versicolor. J. Nat. Prod. 2009, 72, 666-670.
36. Xu, Y.; He, H.; Schulz, S.; Liu, X.; Fusetani, N.; Xiong, H.; Xiao, X.; Qian, P.Y. Potent antifouling compounds produced by marine Streptomyces. Bioresource Technol. 2010, 101, 1331-1336.
37. Dash, S.; Jin, C.; Lee, O.O.; Xu, Y.; Qian, P.Y. Antibacterial and antilarval-settlement potential and metabolite profiles of novel sponge-associated marine bacteria. J. Ind. Microbiol. Biotechnol. 2009, 36, 1047-1056.
38. Xiong, H.; Qi, S.; Xu, Y.; Miao, L.; Qian, P.-Y. Antibiotic and antifouling compound production by the marine-derived fungus Cladosporium sp. F14. J. Hydro-environ. Res. 2009, 2, 264-270.
39. Zhang, L.; An, R.; Wang, J.; Sun, N.; Zhang, S.; Hu, J.; Kuai, J. Exploring novel bioactive compounds from marine microbes. Curr. Opin. Microbiol. 2005, 8, 276-281.
40. Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. Drug development from marine natural products. Nat. Rev. Drug Discov. 2009, 8, 69-85.
41. Sarkar, S.; Saha, M.; Roy, D.; Jaisankar, P.; Das, S.; Gauri Roy, L.; Gachhui, R.; Sen, T.; Mukherjee, J. Enhanced production of antimicrobial compounds by three salt-tolerant actinobacterial strains isolated from the Sundarbans in a niche-mimic bioreactor. Mar. Biotechnol. 2008, 10, 518-526.
42. Rohwer, F.; Breitbart, M.; Jara, J.; Azam, F.; Knowlton, N. Diversity of bacteria associated with the Caribbean coral Montastraea franksi. Coral Reef. 2001, 20, 85-91.
43. Dobretsov, S.; Dahms, H.U.; Tsoi, M.Y.; Qian, P.Y. Chemical control of epibiosis by Hong Kong sponges: The effect of sponge extracts on micro- and macrofouling communities. Mar. Ecol. Prog. Ser. 2005, 297, 119-129.
44. Taylor, M.W.; Schupp, P.J.; Dahllof, I.; Kjelleberg, S.; Steinberg, P.D. Host specificity in marine sponge-associated bacteria, and potential implications for marine microbial diversity. Environ. Microbiol. 2004, 6, 121-130.
45. Provasoli, L.; Pintner, I.J. Effect of media and inoculum on morphology of Ulva. J. Phycol. 1977, 13, 56-56
46. Provasoli, L.; Pintner, I.J. Bacteria induced polymorphism in an axenic laboratory strain of Ulva lactuca (Chlorophceae). J. Phycol. 1980, 16, 196-201.
47. Nakanishi, K.; Nishijima, M.; Nishimura, M.; Kuwano, K.; Saga, N. Bacteria that induce morphogenesis in Ulva pertusa (Chlorophyta) grown under axenic conditions. J. Phycol. 1996, 32, 479-482.
48. Nakanishi, K.; Nishijima, M.; Nomoto, A.M.; Yamazaki, A.; Saga, N. Requisite morphologic interaction for attachment between Ulva pertusa (Chlorophyta) and symbiotic bacteria. Mar. Biotechnol. 1999, 1, 107-111.
49. Matsuo, Y.; Suzuki, M.; Kasai, H.; Shizuri, Y.; Harayama, S. Isolation and phylogenetic characterization of bacteria capable of inducing differentiation in the green alga Monostroma oxyspermum. Environ. Microbiol. 2003, 5, 25-35.
50. Sharp, K.H.; Eam, B.; John Faulkner, D.; Haygood, M.G. Vertical transmission of diverse microbes in the tropical sponge Corticium sp. Appl. Environ. Microbiol. 2007, 73, 622-629.
51. Schmitt, S.; Weisz, J.B.; Lindquist, N.; Hentschel, U. Vertical transmission of a phylogenetically complex microbial consortium in the viviparous sponge Ircinia felix. Appl. Environ. Microbiol. 2007, 73, 2067-2078.
52. Cary, S.C. Verticial transmission of a chemoautotrophic symbiont in the protobranch bivalve, Solemya reidi. Mol. Mar. Biol. Biotechnol. 1994, 3, 121-130.
53. Hirose, E.; Fukuda, T. Vertical transmission of photosymbionts in the colonial ascidian Didemnum molle: The larval tunic prevents symbionts from attaching to the anterior part of larvae. Zool. Sci. 2006, 23, 669-674.
54. Buchan, A.; Gonzalez, J.M.; Moran, M.A. Overview of the marine Roseobacter lineage. Appl. Environ. Microbiol. 2005, 71, 5665-5677.
55. Wagner-Dobler, I.; Biebl, H. Environmental Biology of the Marine Roseobacter Lineage. Annu. Rev. Microbiol. 2006, 60, 255-280.
56. Wilkinson, C.R. Nutrient translocation from symbiotic cyanobacteria to coral reef sponges. In Biologie des Spongiaires; Levi C., Boury-Esnault N. Eds.; Colloques Internationionaux du Centre National de la Recherche Scientifique: Paris. France, 1979; 373-380.
57. Wilkinson, C.R. Net primary productivity in coral reef sponges. Science 1983, 219, 410-412.
58. Stierle, A.C.; Cardellina Ii, J.H.; Singleton, F.L. A marine Micrococcus produces metabolites ascribed to the sponge Tedania ignis. Experientia 1988, 44, 1021.
59. Kobayashi, J.; Ishibashi, M. Bioactive metabolites of symbiotic marine microorganisms. Chem. Rev. 1993, 93, 1753-1769.
60. Unson, M.D.; Faulkner, D.J. Cyanobacterial symbiont synthesis of chlorinated metabolites from Dysidea herbacea (Porifera). Experientia 1993, 44, 1021-1022.
61. Unson, M.D.; Holland, N.D.; Faulkner, D.J. A brominated secondary metabolite synthesized by the cyanobacterial symbiont of a marine sponge and accumulation of the crystalline metabolite in the sponge tissue. Mar. Biol. 1994, 119, 1-12.
62. Oclarit, J.M.; Okada, H.; Ohta, S.; Kaminura, K.; Yamaoka, Y.; Iizuka, T.; Miyashiro, S.; Ikegami, S. Anti-bacillus substance in the marine sponge, Hyatella species, produced by an associated Vibrio species bacterium. Microbios 1994, 78, 7-16.
63. Bewley, C.A.; Holland, N.D.; Faulkner, D.J. Two classes of metabolites from Theonella swinhoei are localized in distinct populations of bacterial symbionts. Experientia 1996, 52, 716-722.
64. Schmidt, E.W.; Obraztsova, A.Y.; Davidson, S.K.; Faulkner, D.J.; Haygood, M.G. Identification of the antifungal peptide-containing symbiont of the marine sponge Theonella swinhoei as a novel delta-proteobacterium, "Candidatus Entotheonella palauensis". Mar. Biol. 2000, 136, 969-977.
65. Schmidt, E.W. From chemical structure to environmental biosynthetic pathways: Navigating marine invertebrate-bacteria associations. Trends Biotechnol. 2005, 23, 437-440.
66. Konig, G.M.; Kehraus, S.; Seibert, S.F.; Abdel-Lateff, A.; Muller, D. Natural products from marine organisms and their associated microbes. Chembiochem 2006, 7, 229-238.
67. Sudek, S.; Lopanik, N.B.; Waggoner, L.E.; Hildebrand, M.; Anderson, C.; Liu, H.; Patel, A.; Sherman, D.H.; Haygood, M.G. Identification of the putative bryostatin polyketide synthase gene cluster from "Candidatus Endobugula sertula", the uncultivated microbial symbiont of the marine bryozoan Bugula neritina. J. Nat. Prod. 2007, 70, 67-74.
68. Lopanik, N.; Gustafson, K.R.; Lindquist, N. Structure of bryostatin 20: A symbiont-produced chemical defense for larvae of the host bryozoan, Bugula neritina J. Nat. Prod. 2004, 67, 1412-1414.
69. Harder, T. Marine epibiosis: Concepts, ecological consequences and host defence. In Marine and Industrial Biofouling; Costerton J.W. Ed.; Springer-Verlag: Berlin, Germany, 2009; pp. 219-231.
70. Egan, S.; James, S.; Holmstrom, C.; Kjelleberg, S. Inhibition of algal spore germination by the marine bacterium Pseudoalteromonas tunicata. FEMS Microbiol. Ecol. 2001, 35, 67-73. (Pubitemid 32436363)
71. Egan, S.; James, S.; Holmstrom, C.; Kjelleberg, S. Correlation between pigmentation and antifouling compounds produced by Pseudoalteromonas tunicata. Environ. Microbiol. 2002, 4, 433-442.
72. Franks, A.; Egan, S.; Holmstrom, C.; James, S.; Lappin-Scott, H.; Kjelleberg, S. Inhibition of fungal colonization by Pseudoalteromonas tunicata provides a competitive advantage during surface colonization. Appl. Environ. Microbiol. 2006, 72, 6079-6087. (Pubitemid 44414639)
73. Holmstrom, C.; James, S.; Neilan, B.A.; White, D.C.; Kjelleberg, S. Pseudoalteromonas tunicata sp. nov., a bacterium that produces antifouling agents. Int. J. Syst. Bacteriol. 1998, 48, 1205-1212. (Pubitemid 28523333)
74. Gil-Turnes, M.S.; Fenical, W. Embryos of Homarus americanus are protected by epibiotic bacteria. Biol. Bull. 1992, 182, 105-108. (Pubitemid 23396279)
75. Lemos, M.L.; Toranzo, A.E.; Barja, J.L. Antibiotic activity of epiphytic bacteria isolated from intertidal seaweeds. Microb. Ecol. 1985, 11, 149-163.
76. Wilson, G.S.; Raftos, D.A.; Corrigan, S.L.; Nair, S.V. Diversity and antimicrobial activities of surface-attached marine bacteria from Sydney Harbour, Australia. Microbiol. Res. 2009.
77. Singh, S.B.; Barrett, J.F. Empirical antibacterial drug discovery - Foundation in natural products. Biochem. Pharmacol. 2006, 71, 1006-1015. (Pubitemid 43306793)
78. Pelaez, F. The historical delivery of antibiotics from microbial natural products - Can history repeat? Biochem. Pharmacol. 2006, 71, 981-990. (Pubitemid 43306790)
79. Staley, J.T.; Konopka, A. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu. Rev. Microbiol. 1985, 39, 321-346.
80. Pace, N.R. A molecular view of microbial diversity and the biosphere. Science 1997, 276, 734-740.
81. Ward, D.M.; Weller, R.; Bateson, M.M. 16S rRNA sequences reveal numerous uncultured microorganisms in a natural community. Nature 1990, 345, 63-65. (Pubitemid 20152451)
82. Jensen, P.R.; Kauffman, C.A.; Fenical, W. High recovery of culturable bacteria from the surfaces of marine algae. Marine Biology 1996, 126, 1-7. (Pubitemid 26309915)
83. DeLong, E.F. The microbial ocean from genomes to biomes. Nature 2009, 459, 200-206.
84. Tripp, H.J.; Kitner, J.B.; Schwalbach, M.S.; Dacey, J.W.H.; Wilhelm, L.J.; Giovannoni, S.J. SAR11 marine bacteria require exogenous reduced sulphur for growth. Nature 2008, 452, 741-744.
85. Kaeberlein, T.; Lewis, K.; Epstein, S.S. Isolating " uncultivabte" microorganisms in pure culture in a simulated natural environment. Science 2002, 296, 1127-1129.
86. Osinga, R.; Armstrong, E.; Grant Burgess, J.; Hoffmann, F.; Reitner, J.; Schumann-Kindel, G. Sponge-microbe associations and their importance for sponge bioprocess engineering. Hydrobiologia 2001, 461, 55-62. (Pubitemid 34067989)
87. Hinde, R.; Pironet, F.; Borowitzka, M.A. Isolation of Oscillatoria spongeliae, the filamentous cyanobacterial symbiont of the marine sponge Dysidea herbacea. Mar. Biol. 1994, 119, 99-104.
88. Betina, V. Bioactive secondary metabolites of microorganisms. Prog. Ind. Microbiol. 1994, 30.
89. Aharonowitz, Y. Nitrogen metabolite regulation of antibiotic biosynthesis. Annu. Rev. Microbiol. 1980, 34, 209-233.
90. Barberel, S.I.; Walker, J.R.L. The effect of aeration upon the secondary metabolism of microorganisms. Biotechnol. Genet. Eng. Rev. 2000, 17, 281-323.
91. Pfefferle, C.; Theobald, U.; Gurtler, H.; Fiedler, H. Improved secondary metabolite production in the genus Streptosporangium by optimization of the fermentation conditions. J. Biotechnol. 2001, 23, 135-142. (Pubitemid 30450147)
92. Schimana, J.; Gebhardt, K.; Holtzel, A.; Schmid, D.G.; Sussmuth, R.; Muller, J.; Pukall, R.; Fiedler, H.P. Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tu 6075. I. Taxonomy, fermentation, isolation and biological activities. J. Antibiot. (Tokyo) 2002, 55, 565-570. (Pubitemid 34752601)
93. Saitoh, K.; Tenmyo, O.; Yamamoto, S.; Furumai, T.; Oki, T. Pradimicin S, a new pradimicin analog I. Taxonomy, fermentation and biological activities. J. Antibiot. (Tokyo) 1993, 46, 580-588.
94. Shimada, N.; Hasegawa, S.; Harada, T. Oxetanocin, a novel nucleoside from bacteria. J. Antibiot. (Tokyo) 1986, 39, 1623-1625.
95. Bills, G.F.; Platas, G.; Fillola, A.; Jimenez, M.R.; Collado, J.; Vicente, F.; MartÃ-n, J.; González, A.; Bur-Zimmermann, J.; Tormo, J.R.; Pelaez, F. Enhancement of antibiotic and secondary metabolite detection from filamentous fungi by growth on nutritional arrays. J. Appl. Microbiol. 2008, 104, 1644-1658.
96. Minas, W.; Bailey, J.E.; Duetz, W. Streptomycetes in micro-cultures: Growth, production of secondary metabolites, and storage and retrieval in the 96-well format. Anton. Leeuwenhoek Int. J. Gen. M. 2000, 78, 297-305.
97. Knight, V.; Sanglier, J.J.; DiTullio, D.; Braccili, S.; Bonner, P.; Waters, J.; Hughes, D.; Zhang, L. Diversifying microbial natural products for drug discovery. Appl. Microbiol. Biotechnol. 2003, 62, 446-458.
98. Matz, C.; Webb, J.S.; Schupp, P.J.; Phang, S.Y.; Penesyan, A.; Egan, S.; Steinberg, P.; Kjelleberg, S. Marine biofilm bacteria evade eukaryotic predation by targeted chemical defense. PLoS ONE 2008, 3, e2744.
99. Yan, L.; Boyd, K.G.; Grant Burgess, J. Surface attachment induced production of antimicrobial compounds by marine epiphytic bacteria using modified roller bottle cultivation. Mar. Biotechnol. 2002, 4, 356-366.
100. Okazaki, T.; Kitahara, T.; Okami, Y. Studies on marine microorganisms. IV. A new antibiotic SS-228 Y produced by Chainia isolated from shallow sea mud. J. Antibiot. (Tokyo) 1975, 28, 176-184.
101. Tyson, G.W.; Lo, I.; Baker, B.J.; Allen, E.E.; Hugenholtz, P.; Banfield, J.F. Genome-directed isolation of the key nitrogen fixer Leptospirillum ferrodiazotrophum sp. nov. from an acidophilic microbial community. Appl. Environ. Microbiol. 2005, 71, 6319-6324.
102. Handelsman, J. Metagenomics: Application of genomics to uncultured microorganisms. Microbiol. Mol. Biol. Rev. 2004, 68, 669-685.
103. Handelsman, J. How to find new antibiotics. Scientist 2005, 19, 20-21.
104. Langer, M.; Gabor, E.M.; Liebeton, K.; Meurer, G.; Niehaus, F.; Schulze, R.; Eck, J.; Lorenz, P. Metagenomics: An inexhaustible access to nature's diversity. Biotechnol. J. 2006, 1, 815-821.
105. Sleator, R.D.; Shortall, C.; Hill, C. Metagenomics. Lett. Appl. Microbiol. 2008, 47, 361-366.
106. Osburne, M.S.; Grossman, T.H.; August, P.R.; MacNeil, I.A. Tapping into microbial diversity for natural products drug discovery. ASM News 2000, 66, 411-417.
107. Daniel, R. The soil metagenome - A rich resource for the discovery of novel natural products. Curr. Opin. Biotechnol. 2004, 15, 199-204.
108. Wang, G.Y.S.; Graziani, E.; Waters, B.; Pan, W.; Li, X.; McDermott, J.; Meurer, G.; Saxena, G.; Andersen, R.J.; Davies, J. Novel natural products from soil DNA libraries in a streptomycete host. Org. Lett. 2000, 2, 2401-2404.
109. Brady, S.F.; Clardy, J. Long-chain N-acyl amino acid antibiotics isolated from heterologously expressed environmental DNA [20]. J. Am. Chem. Soc. 2000, 122, 12903-12904.
110. MacNeil, I.A.; Tiong, C.L.; Minor, C.; August, P.R.; Grossman, T.H.; Loiacono, K.A.; Lynch, B.A.; Phillips, T.; Narula, S.; Sundaramoorthi, R.; Tyler, A.; Aldredge, T.; Long, H.; Gilman, M.; Holt, D.; Osburne, M.S. Expression and isolation of antimicrobial small molecules from soil DNA libraries. J. Mol. Microbiol. Biotechnol. 2001, 3, 301-308.
111. Uria, A.; Piel, J. Cultivation-independent approaches to investigate the chemistry of marine symbiotic bacteria. Phytochem. Rev. 2009, 1-14.
112. Burke, C.; Thomas, T.; Egan, S.; Kjelleberg, S. The use of functional genomics for the identification of a gene cluster encoding for the biosynthesis of an antifungal tambjamine in the marine bacterium Pseudoalteromonas tunicata: Brief report. Environ. Microbiol. 2007, 9, 814-818.
113. Lefevre, F.; Robe, P.; Jarrin, C.; Ginolhac, A.; Zago, C.; Auriol, D.; Vogel, T.M.; Simonet, P.; Nalin, R. Drugs from hidden bugs: Their discovery via untapped resources. Res. Microbiol. 2008, 159, 153-161.
114. Brady, S.F.; Chao, C.J.; Clardy, J. Long-chain N-acyltyrosine synthases from environmental DNA. Appl. Environ. Microbiol. 2004, 70, 6865-6870.
115. Henne, A.; Schmitz, R.A.; Bomeke, M.; Gottschalk, G.; Daniel, R. Screening of environmental DNA libraries for the presence of genes conferring lipolytic activity on Escherichia coli. Appl. Environ. Microbiol. 2000, 66, 3113-3116.
116. Schloss, P.D.; Handelsman, J. Biotechnological prospects from metagenomics. Curr. Opin. Biotechnol. 2003, 14, 303-310.
117. Handelsman, J. Sorting out metagenomes. Nat. Biotechnol. 2005, 23, 38-39.
118. Sarovich, D.S.; Pemberton, J.M. pPSX: A novel vector for the cloning and heterologous expression of antitumor antibiotic gene clusters. Plasmid 2007, 57, 306-313.
119. Díaz, M.; Ferreras, E.; Moreno, R.; Yepes, A.; Berenguer, J.; Santamaría, R. High-level overproduction of Thermus enzymes in Streptomyces lividans. Appl. Microbiol. Biotechnol. 2008, 79, 1001-1008.
120. Butzin, N.C.; Owen, H.A.; Collins, M.L.P. A new system for heterologous expression of membrane proteins: Rhodospirillum rubrum. Protein Expr. Purif., In Press.
121. Li, C.; Hazzard, C.; Florova, G.; Reynolds, K.A. High titer production of tetracenomycins by heterologous expression of the pathway in a Streptomyces cinnamonensis industrial monensin producer strain. Metab. Eng. 2009, 11, 319-327.
122. Foerstner, K.U.; Doerks, T.; Creevey, C.J.; Doerks, A.; Bork, P. A computational screen for type I polyketide synthases in metagenomics shotgun data. PLoS ONE 2008, 3.
123. Thomas, T.; Evans, F.F.; Schleheck, D.; Mai-Prochnow, A.; Burke, C.; Penesyan, A.; Dalisay, D.S.; Stelzer-Braid, S.; Saunders, N.; Johnson, J.; Ferriera, S.; Kjelleberg, S.; Egan, S. Analysis of the Pseudoalteromonas tunicata genome reveals properties of a surface-associated life style in the marine environment. PLoS ONE 2008, 3, e3252.
124. Blasiak, L.C.; Clardy, J. Discovery of 3-formyl-tyrosine metabolites from Pseudoalteromonas tunicata through heterologous expression. J. Am. Chem. Soc. 2009.
125. Silakowski, B.; Kunze, B.; Muller, R. Multiple hybrid polyketide synthase/non-ribosomal peptide synthetase gene clusters in the myxobacterium Stigmatella aurantiaca. Gene 2001, 275, 233-240.
126. Bok, J.W.; Hoffmeister, D.; Maggio-Hall, L.A.; Murillo, R.; Glasner, J.D.; Keller, N.P. Genomic mining for Aspergillus natural products. Chem. Biol. 2006, 13, 31-37.
127. Firn, R.D.; Jones, C.G. The evolution of secondary metabolism-a unifying model. Mol. Microbiol. 2000, 37, 989-994.
128. Handelsman, J.; Rondon, M.R.; Brady, S.F.; Clardy, J.; Goodman, R.M. Molecular biological access to the chemistry of unknown soil microbes: A new frontier for natural products. Chem. Biol. 1998, 5, R245-R249.
129. Lane, D.J. 16S/23S rRNA sequencing. In Nucleic acid techniques in bacterial systematics; Stackebrandt, E., Goodfellow, M., Eds.; John WIley & Sons: New York, NY, USA, 1991; pp. 115-147.
130. Mitova, M.I.; Murphy, A.C.; Lang, G.; Blunt, J.W.; Cole, A.L.J.; Ellis, G.; Munro, M.H.G. Evolving trends in the dereplication of natural product extracts. 2. The isolation of chrysaibol, an antibiotic peptaibol from a New Zealand sample of the mycoparasitic fungus Sepedonium chrysospermum. J. Nat. Prod. 2008, 71, 1600-1603.
131. Nielen, M.W.F.; Hooijerink, H.; Claassen, F.C.; van Engelen, M.C.; van Beek, T.A. Desorption electrospray ionisation mass spectrometry: A rapid screening tool for veterinary drug preparations and forensic samples from hormone crime investigations. Anal. Chim. Acta 2009, 637, 92-100.
132. Williams, J.P.; Scrivens, J.H. Rapid accurate mass desorption electrospray ionisation tandem mass spectrometry of pharmaceutical samples. Rapid Commun. Mass Spectrom. 2005, 19, 3643-3650.
133. Jensen, P.R.; Mincer, T.J.; Williams, P.G.; Fenical, W. Marine actinomycete diversity and natural product discovery. Anton. Leeuwenhoek 2005, 87, 43-48.
134. Maldonado, L.A.; Fenical, W.; Jensen, P.R.; Kauffman, C.A.; Mincer, T.J.; Ward, A.C.; Bull, A.T.; Goodfellow, M. Salinispora arenicola gen. nov., sp. nov. and Salinispora tropica sp. nov., obligate marine actinomycetes belonging to the family Micromonosporaceae. Int. J. Syst. Evol. Microbiol. 2005, 55, 1759-1766.
135. Williams, P.G.; Buchanan, G.O.; Feling, R.H.; Kauffman, C.A.; Jensen, P.R.; Fenical, W. New cytotoxic salinosporamides from the marine actinomycete Salinispora tropica. J. Org. Chem. 2005, 70, 6196-6203. (Pubitemid 41076500)
136. Boonlarppradab, C.; Kauffman, C.A.; Jensen, P.R.; Fenical, W. Marineosins A and B, cytotoxic spiroaminals from a sarine-serived Actinomycete. Org. Lett. 2008, 10, 5505-5508.
137. Taori, K.; Paul, V.J.; Luesch, H. Structure and activity of largazole, a potent anti-proliferative agent from the Floridian marine cyanobacterium Symploca sp. J. Am. Chem. Soc. 2008, 130, 1806-1807.
138. Hill, R.A. Marine natural products. Annu. Rep. Prog. Chem. Sect. B: Org. Chem. 2009, 105, 150-166.
139. Jensen, P.R.; Fenical, W. Strategies for the discovery of secondary metabolites from marine bacteria: Ecological perspectives. Annu. Rev. Microbiol. 1994, 48, 559-584. (Pubitemid 24334109)
140. Williams, P.G. Panning for chemical gold: Marine bacteria as a source of new therapeutics. Trends Biotechnol. 2009, 27, 45-52.
141. Monaghan, R.L.; Polishook, J.D.; Pecore, V.J.; Bills, G.F.; Nallin-Omstead, M.; Streicher, S.L. Discovery of novel secondary metabolites from fungi-Is it really a random walk through a random forest? Can. J. Bot. 1995, 73, S925-S931.
142. Koehn, F.E.; Carter, G.T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 2005, 4, 206-220. (Pubitemid 40372555)
143. Strobel, G.A. Rainforest endophytes and bioactive products. Crit. Rev. Biotechnol. 2002, 22, 315-333.
144. Frenich, A.G.; Vidal, J.L.M.; Romero-Gonzalez, R.; Aguilera-Luiz, M.d.M. Simple and high-throughput method for the multimycotoxin analysis in cereals and related foods by ultra-high performance liquid chromatography/tandem mass spectrometry. Food Chem. 2009, 117, 705-712.
145. Rowe, B.; Schmidt, J.J.; Smith, L.A.; Ahmed, S.A. Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activity. Anal. Biochem. 2010, 396, 188-193.
146. Bull, A.T.; Stach, J.E.M. Marine actinobacteria: New opportunities for natural product search and discovery. Trends Microbiol. 2007, 15, 491-499.
147. Cardellina, J.H. A place for natural products? Screening 2006, 7, 28-30.
148. Koehn, F.E., High impact technologies for natural products screening. Prog. Drug Res. 2008, 65, 176-210.
149. Lam, K.S. New aspects of natural products in drug discovery. Trends Microbiol. 2007, 15, 279-289. (Pubitemid 46856162)
150. Bugni, T.S.; Richards, B.; Bhoite, L.; Cimbora, D.; Harper, M.K.; Ireland, C.M. Marine natural product libraries for high-throughput screening and rapid drug discovery. J. Nat. Prod. 2008, 71, 1095-1098.
151. Floss, H.G. Combinatorial biosynthesis-Potential and problems. J. Biotechnol. 2006, 124, 242-257.
152. Alksne, L.E.; Dunman, P.M., Target-based antimicrobial drug discovery. Methods Mol. Biol. 2007, 431, 271-283.
153. Alvarez, J.; Vicente, M. Using genomics to identify new targets and counteract resistance to antibiotics. Expert Opin. Ther. Pat. 2007, 17, 667-674. (Pubitemid 47045529)
154. Dougherty, T.J.; Barrett, J.F.; Pucci, M.J. Microbial genomics and novel antibiotic discovery: New technology to search for new drugs. Curr. Pharm. Des. 2002, 8, 1119-1135.
155. Dougherty, T.J.; Miller, P.F. Microbial genomics and drug discovery: Exploring innovative routes of drug discovery in the postgenomic era. IDrugs 2006, 9, 420-422.
156. Monaghan, R.L.; Barrett, J.F. Antibacterial drug discovery-Then, now and the genomics future. Biochem. Pharmacol. 2006, 71, 901-909. (Pubitemid 43306782)
157. Payne, D.J.; Gwynn, M.N.; Holmes, D.J.; Pompliano, D.L. Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat. Rev. Drug. Discov. 2007, 6, 29-40.
158. Walsh, C. Where will new antibiotics come from? Nat. Rev. Microbiol. 2003, 1, 65-70.
159. Butler, M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod. 2004, 67, 2141-2153. (Pubitemid 40092578)
160. Muller-Kuhrt, L. Putting nature back into drug discovery. Nat. Biotechnol. 2003, 21, 602. (Pubitemid 36638081)
161. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as a source of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66, 1002-1037.
162. Overbye, K.M.; Barrett, J.F. Antibiotics: Where did we go wrong? Drug Discov. Today 2005, 10, 45-52.
163. Norrby, S.R.; Nord, C.E.; Finch, R. Lack of development of new antimicrobial drugs: A potential serious threat to public health. Lancet Infect. Dis. 2005, 5, 115-119. (Pubitemid 40174782)
164. Projan, S.J. Why is big pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. 2003, 6, 427-430.
165. Larsson, J.; Gottfries, J.; Muresan, S.; Backlund, A. ChemGPS-NP: Tuned for navigation in biologically relevant chemical space. J. Nat. Prod. 2007, 70, 789-794. (Pubitemid 46953601)
166. Larsen, T.O.; Smedsgaard, J.; Nielsen, K.F.; Hansen, M.E.; Frisvad, J.C. Phenotypic taxonomy and metabolite profiling in microbial drug discovery. ChemInform 2006, 37.
167. Nicolaou, K.C.; Frederick, M.O.; Petrovic, G.; Cole, K.P.; Loizidou, E.Z. Total synthesis and confirmation of the revised structures of azaspiracid-2 and azaspiracid-3. Angew. Chem. Int. Ed. 2006, 45, 2609-2615.
168. Nicolaou, K.C.; Zhang, H.; Chen, J.S.; Crawford, J.J.; Pasunoori, L. Total synthesis and stereochemistry of uncialamycin. Angew. Chem. Int. Ed. 2007, 46, 4704-4707.
169. Tillmann, U.; Elbrächter, M.; Krock, B.; John, U.; Cembella, A. Azadinium spinosum gen. et sp. nov. (Dinophyceae) identified as a primary producer of azaspiracid toxins. Eur. J. Phycol. 2009, 44, 63-79.
170. Crimmins, M.T.; Zuccarello, J.L.; Ellis, J.M.; McDougall, P.J.; Haile, P.A.; Parrish, J.D.; Emmitte, K.A. Total synthesis of Brevetoxin A. Org. Lett. 2009, 11, 489-492.
171. Haywood, A.J.; Scholin, C.A.; Marin Iii, R.; Steidinger, K.A.; Heil, C.; Ray, J. Molecular detection of the brevetoxin-producing dinoflagellate Karenia brevis and closely related species using rRNA-targeted probes and a semiautomated sandwich hybridization assay. J. Phycol. 2007, 43, 1271-1286.
172. Feher, M.; Schmidt, J.M. Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci. 2003, 43, 218-227.
173. Henkel, T.; Brunne, R.M.; Muller, H.; Reichel, F. Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew. Chem. Int. Ed. 1999, 38, 643-647.
174. Verdine, G. The combinatorial chemistry of nature. Nature 1996, 384, 11-13.
175. Tulp, M.; Bohlin, L. Unconventional natural sources for future drug discovery. Drug Discov. Today 2004, 9, 450-458.
176. Newman, D.; Cragg, G.; Kingston, D., Natural products as pharmaceuticals and sources for lead structures. In The Practice of Medicinal Chemistry, 2nd ed.; Wermuth, C.G., Ed.; Academic Press: London, UK, 2003; pp. 91-110.
177. Nisbet, L.J.; Moore, M. Will natural products remain an important source of drug research for the future? Curr. Opin. Biotechnol. 1997, 8, 708-712.
178. Nicolaou, K.C.; Chen, J.S.; Edmonds, D.J.; Estrada, A.A. Recent advances in the chemistry and biology of naturally occurring antibiotics. Angew. Chem. Int. Ed. 2009, 48, 660-719.
179. Breinbauer, R.; Vetter, I.R.; Waldmann, H. From protein domains to drug candidates - natural products as guiding principles in compound library design and synthesis. Ernst Schering Res. Found. Workshop 2003, 167-188.
180. Urizar, N.L.; Liverman, A.B.; Dodds, D.T.; Silva, F.V.; Ordentlich, P.; Yan, Y.Z.; Gonzalez, F.J.; Heyman, R.A.; Mangelsdorf, D.J.; Moore, D.D. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science 2002, 296, 1703-1706.
181. Von Nussbaum, F.; Brands, M.; Hinzen, B.; Weigand, S.; HÃbich, D. Antibacterial natural products in medicinal chemistry-Exodus or revival? Angew. Chem. Int. Ed. 2006, 45, 5072-5129.
182. Demain, A.L.; Sanchez, S. Microbial drug discovery: 80 Years of progress. J. Antibiot. (Tokyo) 2009, 62, 5-16.
183. Walters, W.P.; Murcko, A.; Murcko, M.A. Recognizing molecules with drug-like properties. Curr. Opin. Chem. Biol. 1999, 3, 384-387.
184. Leeson, P.D.; Davis, A.M.; Steele, J. Drug-like properties: Guiding principles for design-Or chemical prejudice? Drug Discov. Today 2004, 1, 189-195.
185. Jenkins, I.D.; Lacrampe, F.; Ripper, J.; Alcaraz, L.; Van Le, P.; Nikolakopoulos, G.; De Leone, P.A.; White, R.H.; Quinn, R.J. Synthesis of four novel natural product inspired scaffolds for drug discovery. J. Org. Chem. 2009, 74, 1304-1313.
186. Bollag, D.M.; McQueney, P.A.; Zhu, J.; Hensens, O.; Koupal, L.; Liesch, J.; Goetz, M.; Lazarides, E.; Woods, C.M. Epothilones, a new class of microtubule-stabilizing agents with a taxol- like mechanism of action. Cancer Res. 1995, 55, 2325-2333.
187. Nicolaou, K.; Scarpelli, R.; Bollbuck, B.; Werschkun, B.; Pereira, M.; Wartmann, M.; Altmann, K.H.; Zaharevitz, D.; Gussio, R.; Giannakakou, P. Chemical synthesis and biological properties of pyridine epothilones. Chem. Biol. 2000, 7, 593-599.
188. Nicolaou, K.C.; Pratt, B.A.; Arseniyadis, S.; Wartmann, M.; O'Brate, A.; Giannakakou, P. Molecular design and chemical synthesis of a highly potent epothilone. ChemMedChem 2006, 1, 41-44.